APEN

Apollo Endosurgery, Inc. (APEN) | Rumor.io

Apollo Endosurgery

APEN

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about APEN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

Apr 4

Apollo Endosurgery has been acquired by Boston Scientific Corporation.
Several directors and the Chief Financial Officer have disposed of their shares in Apollo Endosurgery, decreasing their holdings to zero.
Apollo Endosurgery's RSI indicator has left the overbought zone, potentially indicating a price drop.

Generated by AI

Sentiment

Of the messages about APEN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% 0
Bearish	—	—	—	0% 0

Bullish· Nov 29

Apollo Endosurgery's stock has soared to one-year highs following buyout news, reaching $417 million in deal value.
The company's market capitalization has increased, with the deal expected to close in the first half of 2023, providing a favorable risk-reward scenario.
Long-term investors who purchased the stock in the summer have seen significant gains, with the potential for further upside to $1.26 and beyond.

Bearish· Mar 1

$APEN may experience a short squeeze, which could lead to a sharp increase in price.
The stock's recent surge may be a result of a pump and dump scheme, and it's likely to dump again once the shorts have covered.
The FDA approval, while a positive development, may not be enough to sustain the stock's price, as the company's history of taking money from investors suggests a high risk of losing value.

Generated by AI

Topics

Of the messages about APEN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Earnings· Mar 1

Apollo Endosurgery reported earnings that missed expectations by $0.08.
The company missed revenue estimates in its earnings report.
Apollo Endosurgery is scheduled to release its earnings on March 1 after the close.

Announcements· Apr 4

Apollo Endosurgery ($APEN) was acquired by Boston Scientific Corporation ($BSX) on April 4, 2023.
Apollo Endosurgery ($APEN) has filed SEC form 4, disclosing that several directors and executives have disposed of their shares, resulting in a 100% decrease in their holdings.
Apollo Endosurgery ($APEN) has been delisted from the exchange and has terminated a material definitive agreement, as reported in its SEC form 8-K filing.

Technical Analysis· Mar 1

$APEN has a low float, high short interest, and 70% of float locked up, which could impact its price movement.
The stock has shown a strong bounce back from weekly resistance at 7.91 and needs to close above 6.50 to retest 7.91 and continue its uptrend.
Key indicators for an uptrend in $APEN include a price above 7.95, confirmation at 8.33, a mini breakout at 9.26, and a full breakout at 9.71.

Generated by AI

Community

Of the messages about APEN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	0%
Newcomers	—	—	—	100%

Also Discussed

Investors talking about APEN also mention

#	Name	Attention
1	ASLN - ASLAN Pharmaceuticals Limited	——
2	GNFT - Genfit S.A.	——
3	Scopus Biopharma Inc.SCPS	0%new
4	Atlantic American CorpAAME	0%new
5	Socket Mobile Inc.SCKT	0%0
6	TDH Holdings, Inc.PETZ	0%new
7	MORF - Morphic Holding, Inc.	——
8	DYNT - Dynatronics Corporation	——
9	TLIS - Talis Biomedical Corporation	——
10	OBLN - Obalon Therapeutics, Inc.	——